Fig. 6From: In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancerHemolytic study of PAMAM G4.5-piperazinyl-FITC. The study was performed by incubating red blood cells from dog with 5 or 50 µM dendrimer concentrations at 4 and 24 h. The percent hemolysis was calculated considering the positive control of hemolysis (SDS 2 %) as 100 % of hemolysisBack to article page